Raymond James & Associates’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-13,683
| Closed | -$138K | – | 3618 |
|
|
2018
Q3 | $138K | Sell |
13,683
-4,800
| -26% | -$48.4K | ﹤0.01% | 3350 |
|
|
2018
Q2 | $134K | Buy |
18,483
+250
| +1% | +$1.81K | ﹤0.01% | 3324 |
|
|
2018
Q1 | $110K | Sell |
18,233
-12,775
| -41% | -$77.1K | ﹤0.01% | 3224 |
|
|
2017
Q4 | $298K | Buy |
31,008
+14,982
| +93% | +$144K | ﹤0.01% | 2820 |
|
|
2017
Q3 | $142K | Buy |
16,026
+4,024
| +34% | +$35.7K | ﹤0.01% | 3099 |
|
|
2017
Q2 | $152K | Buy |
+12,002
| New | +$152K | ﹤0.01% | 3019 |
|
|
2016
Q4 | – | Sell |
-12,116
| Closed | -$143K | – | 3224 |
|
|
2016
Q3 | $143K | Buy |
+12,116
| New | +$143K | ﹤0.01% | 2902 |
|
|
2015
Q4 | – | Sell |
-13,184
| Closed | -$375K | – | 2426 |
|
|
2015
Q3 | $375K | Sell |
13,184
-1,647
| -11% | -$46.8K | ﹤0.01% | 2046 |
|
|
2015
Q2 | $533K | Sell |
14,831
-6,961
| -32% | -$250K | ﹤0.01% | 2057 |
|
|
2015
Q1 | $633K | Buy |
+21,792
| New | +$633K | ﹤0.01% | 1920 |
|
|
2014
Q4 | – | Sell |
-51,880
| Closed | -$1.01M | – | 2334 |
|
|
2014
Q3 | $1.01M | Buy |
51,880
+12,120
| +30% | +$235K | 0.01% | 1489 |
|
|
2014
Q2 | $621K | Buy |
+39,760
| New | +$621K | ﹤0.01% | 1744 |
|